Skip to main content
Equibles
ELTX logo

ELTX · Elicio Therapeutics, Inc. · Proposed Sales

Track ELTX — free

Use ELTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ELTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.56 -0.07 (-4.29%) At close · Nov 12
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Nov 5, 2026

Substantial doubt about the company's ability to continue as a going concern.

“We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway.”
View the 10-Q filed Nov 5, 2026
Market Cap
$44.16M
Shares
28.31M
Volume · Nov 12 232.82K Avg daily vol (3M) 320.42K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1601485 CUSIP 28657F103 13F (30d) 44 filings 43 filers Visit website Investor relations